Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors.

Taynara L Silva, Deborah A Dos Santos, Hugo C R de Jesus, Dieter Brömme, João B Fernandes, Marcio W Paixão, Arlene G Corrêa, Paulo C Vieira

Bioorganic & medicinal chemistry 2020 Aug 01

filter terms:

Cathepsin K (CatK) is a cysteine protease known for its potent collagenolytic activity, being recognized as an important target to the development of therapies for the treatment of bone disorders. Epoxypeptidomimetics have been reported as potent inhibitors of cathepsins, thus in this work we present a green synthesis of new peptidomimetics by using a one-pot asymmetric epoxidation/Ugi multicomponent reaction. The compounds were evaluated against CatK showing selectivity when compared with cathepsin L, with an inhibition profile in the low micromolar IC50 range. Investigation of the mechanism of action carried out for compounds LSPN428 and LSPN694 suggested a mixed inhibition mode and docking studies allowed a better understanding about interactions of inhibitors with the enzyme. Copyright © 2020 Elsevier Ltd. All rights reserved.

Citation

Taynara L Silva, Deborah A Dos Santos, Hugo C R de Jesus, Dieter Brömme, João B Fernandes, Marcio W Paixão, Arlene G Corrêa, Paulo C Vieira. Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors. Bioorganic & medicinal chemistry. 2020 Aug 01;28(15):115597